131 related articles for article (PubMed ID: 12845641)
1. Increased in situ gelatinolytic activity in renal cell tumor tissues correlates with tumor size, grade and vessel invasion.
Kamiya N; Kishimoto T; Suzuki H; Sekita N; Nagai Y; Oosumi N; Kito H; Tochigi N; Shinbo M; Nemori R; Ichikawa T; Igarashi T; Ito H; Ishikura H
Int J Cancer; 2003 Sep; 106(4):480-485. PubMed ID: 12845641
[TBL] [Abstract][Full Text] [Related]
2. In situ gelatinolytic activity correlates with tumor progression and prognosis in patients with bladder cancer.
Kawamura K; Kamiya N; Suyama T; Shimbo M; Oosumi N; Suzuki H; Ueda T; Tobe T; Igarashi T; Ito H; Ishikura H
J Urol; 2004 Oct; 172(4 Pt 1):1480-4. PubMed ID: 15371875
[TBL] [Abstract][Full Text] [Related]
3. Gelatinolytic activity of matrix metalloproteinase in lung cancer studied using film in situ zymography stamp method.
Kaji M; Moriyama S; Sasaki H; Saitoh Y; Kiriyama M; Fukai I; Yamakawa Y; Mitsui A; Toyama T; Nemori R; Fujii Y
Lung Cancer; 2003 Feb; 39(2):125-30. PubMed ID: 12581563
[TBL] [Abstract][Full Text] [Related]
4. Matrix metalloproteinases 2 and 9 in oral squamous cell carcinomas: manifestation and localization of their activity.
Kato K; Hara A; Kuno T; Kitaori N; Huilan Z; Mori H; Toida M; Shibata T
J Cancer Res Clin Oncol; 2005 Jun; 131(6):340-6. PubMed ID: 15614523
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of gelatinolytic activity in tumor tissues by synthetic matrix metalloproteinase inhibitor: application of film in situ zymography.
Ikeda M; Maekawa R; Tanaka H; Matsumoto M; Takeda Y; Tamura Y; Nemori R; Yoshioka T
Clin Cancer Res; 2000 Aug; 6(8):3290-6. PubMed ID: 10955815
[TBL] [Abstract][Full Text] [Related]
6. Examination of in vivo gelatinolytic activity in rheumatoid arthritis synovial tissue using newly developed in situ zymography and image analyzer.
Yoshida W; Uzuki M; Nishida J; Shimamura T; Sawai T
Clin Exp Rheumatol; 2009; 27(4):587-93. PubMed ID: 19772789
[TBL] [Abstract][Full Text] [Related]
7. A quantitative evaluation of active gelatinolytic sites in uterine endometrioid adenocarcinoma using film in situ zymography: association of stronger gelatinolysis with myometrial invasion.
Zheng K; Nagai Y; Kishimoto T; Yamazawa K; Tate S; Nemori R; Hirai Y; Sekiya S; Ishikura H
Jpn J Cancer Res; 2002 May; 93(5):516-22. PubMed ID: 12036447
[TBL] [Abstract][Full Text] [Related]
8. Localization of gelatinase activities in glioma tissues by film in situ zymography.
Takano S; Tsuboi K; Matsumura A; Sato H; Nose T
Brain Tumor Pathol; 2001; 18(2):145-50. PubMed ID: 11908871
[TBL] [Abstract][Full Text] [Related]
9. Expression of matrix metalloproteinases 7 and 2 in human renal cell carcinoma.
Sumi T; Nakatani T; Yoshida H; Hyun Y; Yasui T; Matsumoto Y; Nakagawa E; Sugimura K; Kawashima H; Ishiko O
Oncol Rep; 2003; 10(3):567-70. PubMed ID: 12684625
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of matrix metalloproteinase-2 (MMP-2) activity with film in situ zymography for improved cytological diagnosis of breast tumors.
Fujiwara A; Shibata E; Terashima H; Shishido A; Nishiki J; Yoshida K; Miyauchi K; Madachi A; Matsuura N
Breast Cancer; 2006; 13(3):272-278. PubMed ID: 16929121
[TBL] [Abstract][Full Text] [Related]
11. Gelatinolytic activity of matrix metalloproteinase-2 and -9 in oesophageal carcinoma; a study using in situ zymography.
Koyama H; Iwata H; Kuwabara Y; Iwase H; Kobayashi S; Fujii Y
Eur J Cancer; 2000 Oct; 36(16):2164-70. PubMed ID: 11044656
[TBL] [Abstract][Full Text] [Related]
12. Expression of tissue levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in renal cell carcinoma.
Qiao ZK; Li YL; Lu HT; Wang KL; Xu WH
World J Surg Oncol; 2013 Jan; 11():1. PubMed ID: 23281640
[TBL] [Abstract][Full Text] [Related]
13. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells.
Zhao JX; Yang LP; Wang YF; Qin LP; Liu DQ; Bai CX; Nan X; Shi SS; Pei XJ
Eur J Neurol; 2007 May; 14(5):510-6. PubMed ID: 17437609
[TBL] [Abstract][Full Text] [Related]
14. Matrix metalloproteinase-9 is required for vasculogenic mimicry by clear cell renal carcinoma cells.
Lin H; Pan JC; Zhang FM; Huang B; Chen X; Zhuang JT; Wang H; Mo CQ; Wang DH; Qiu SP
Urol Oncol; 2015 Apr; 33(4):168.e9-16. PubMed ID: 25618297
[TBL] [Abstract][Full Text] [Related]
15. [Relationship between expression of matrix metalloproteinase-9 (MMP-9) and angiogenesis in renal cell carcinoma].
Zhang Y; Wu XH; Cao GH; Li S
Ai Zheng; 2004 Mar; 23(3):326-9. PubMed ID: 15025968
[TBL] [Abstract][Full Text] [Related]
16. Gelatinolytic activity of matrix metalloproteinase in tumor tissues correlates with the invasiveness of oral cancer.
Ikebe T; Shinohara M; Takeuchi H; Beppu M; Kurahara S; Nakamura S; Shirasuna K
Clin Exp Metastasis; 1999 Jun; 17(4):315-23. PubMed ID: 10545018
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of matrix metalloproteinase 9 correlates with poor prognostic variables in renal cell carcinoma.
Cho NH; Shim HS; Rha SY; Kang SH; Hong SH; Choi YD; Hong SJ; Cho SH
Eur Urol; 2003 Nov; 44(5):560-6. PubMed ID: 14572755
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase-2 and -9 in the sera and in the urine of human oncocytoma and renal cell carcinoma.
Di Carlo A
Oncol Rep; 2012 Sep; 28(3):1051-6. PubMed ID: 22711190
[TBL] [Abstract][Full Text] [Related]
19. Protein expression of matrix metalloproteinases 2 and 9 and tissue inhibitors of metalloproteinase 1 and 2 in papillary thyroid carcinomas.
Maeta H; Ohgi S; Terada T
Virchows Arch; 2001 Feb; 438(2):121-8. PubMed ID: 11253113
[TBL] [Abstract][Full Text] [Related]
20. Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival.
Miyata Y; Koga S; Kanda S; Nishikido M; Hayashi T; Kanetake H
Clin Cancer Res; 2003 May; 9(5):1741-9. PubMed ID: 12738729
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
